共 50 条
- [41] Patient perception and approval of fecal microbiota transplantation (FMT) as an alternative treatment option for ulcerative colitis ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (03): : 296 - 303
- [42] Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT) PROBIOTICS AND CHILD GASTROINTESTINAL HEALTH: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 10, 2019, 1125 : 85 - 100
- [43] Safety of Fecal Microbiota Transplantation (FMT) in Immunocompromised (Ic) Patients with Inflammatory Bowel Disease (IBD) AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S556 - S556
- [45] Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 34 (01):
- [46] The Role of Loperamide in Conjunction With Fecal Microbiota Transplantation (FMT) for Recurrent Clostridioides difficile Infection (rCDI) AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S97 - S98
- [47] Effect of Aging on the Composition of Fecal Microbiota in Donors for FMT and Its Impact on Clinical Outcomes Digestive Diseases and Sciences, 2017, 62 : 1002 - 1008
- [49] Treating Clostridioides difficile: Could Microbiota-based Live Biotherapeutic Products Provide the Answer? INFECTION AND DRUG RESISTANCE, 2023, 16 : 3137 - 3143
- [50] Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details INFECTION AND DRUG RESISTANCE, 2024, 17 : 623 - 639